CLINICAL_TRIALS
trial_result
· 2016-10-05
Clinical Trial Update: FK506 (Tacrolimus) in Pulmonary Arterial Hypertension [Phase 2]
Summary
Phase 2 trial results for tacrolimus (FK506) in pulmonary arterial hypertension have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Edda Spiekerkoetter | Conditions: Pulmonary Arterial Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2016-10-05